UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enhanced susceptibility of pediatric airway epithelium to respiratory syncytial virus infection

The Journal of clinical investigation, 2024-11, Vol.134 (21)

2024

Volltextzugriff (PDF)

Long-Term SARS-CoV-2 Findings Related to Persisting Viral Antigen and Inflammation Resemble Those Reported for Influenza Virus and Respiratory Syncytial Virus

Viruses, 2024-09, Vol.16 (9), p.1353

Roberts, Jr, Norbert J

2024

Volltextzugriff (PDF)

Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation

Science (American Association for the Advancement of Science), 2024-09, Vol.385 (6716), p.1484-1491

2024

Volltextzugriff (PDF)

Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection

Expert review of anti-infective therapy, 2024-08, Vol.22 (8), p.631-645

2024

Volltextzugriff (PDF)

Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK

Influenza and other respiratory viruses, 2024-10, Vol.18 (10), p.e70013-n/a

2024

Volltextzugriff (PDF)

Antibody-mediated protection against respiratory syncytial virus in children

European respiratory review, 2024-10, Vol.33 (174), p.240106

2024

Volltextzugriff (PDF)

Induction of neutralizing antibody responses by AAV5-based vaccine for respiratory syncytial virus in mice

Frontiers in immunology, 2024-10, Vol.15, p.1451433

2024

Volltextzugriff (PDF)

A new RSV vaccine (mResvia) for adults ≥60 years old

The Medical letter on drugs and therapeutics (English ed.), 2024-10, Vol.66 (1713), p.166-168

Editors from The Medical Letter

2024

Volltextzugriff (PDF)

Respiratory syncytial virus infection provides protection against severe acute respiratory syndrome coronavirus challenge

Journal of virology, 2024-09, Vol.98 (9), p.e0066924

2024

Volltextzugriff (PDF)

Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children

The Lancet (British edition), 2024-09, Vol.404 (10458), p.1157-1170

2024

Volltextzugriff (PDF)

Promising Top-Line Results for RSV Vaccine in Immunocompromised Adults

JAMA : the journal of the American Medical Association, 2024-10, Vol.332 (13), p.1043

Anderer, Samantha

2024

Volltextzugriff (PDF)

Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis

The Lancet (British edition), 2024-10, Vol.404 (10462), p.1547-1559

2024

Volltextzugriff (PDF)

Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan

Expert review of vaccines, 2024-01, Vol.23 (1), p.986-996

2024

Volltextzugriff (PDF)

Early-Life Respiratory Syncytial Virus (RSV) Infection Triggers Immunological Changes in Gut-Associated Lymphoid Tissues in a Sex-Dependent Manner in Adulthood

Cells (Basel, Switzerland), 2024-10, Vol.13 (20), p.1728

2024

Volltextzugriff (PDF)

Systematic Review of the Efficacy and Safety of RSV‐Specific Monoclonal Antibodies and Antivirals in Development

Reviews in medical virology, 2024-09, Vol.34 (5), p.e2576-n/a

2024

Volltextzugriff (PDF)

The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune Response

International journal of molecular sciences, 2024-09, Vol.25 (18), p.9800

2024

Volltextzugriff (PDF)

Reduced antiviral gene expression and elevated CXCL8 expression in peripheral blood are associated with severe hypoxemia in RSV-infected children

Frontiers in immunology, 2024-09, Vol.15, p.1438630

2024

Volltextzugriff (PDF)

Vaccinations in pulmonary diseases - part 2: herpes zoste, RSV, pneumococcal infection and pertussis

Deutsche medizinische Wochenschrift (1946), 2024-11, Vol.149 (22), p.1372

2024

Volltextzugriff (PDF)

The role of respiratory syncytial virus G protein in immune cell infection and pathogenesis

EBioMedicine, 2024-09, Vol.107, p.105318, Article 105318

2024

Volltextzugriff (PDF)

RSV Neutralizing Antibodies in Dried Blood

The Journal of infectious diseases, 2024-07, Vol.230 (1), p.e93

2024

Volltextzugriff (PDF)

Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024

MMWR. Morbidity and mortality weekly report, 2024-09, Vol.73 (38), p.837-843

2024

Volltextzugriff (PDF)

AntigenBoost: enhanced mRNA-based antigen expression through rational amino acid substitution

Briefings in bioinformatics, 2024-09, Vol.25 (6)

2024

Volltextzugriff (PDF)

Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study

BMC medicine, 2024-10, Vol.22 (1), p.478-12, Article 478

2024

Volltextzugriff (PDF)

Having the conversation: Individualizing RSV vaccination in older patients

Cleveland Clinic journal of medicine, 2024-09, Vol.91 (9 suppl 1), p.S26-S33

Factora, Ronan

2024

Volltextzugriff (PDF)

Circulation of new lineages of RSV-A and RSV-B in Kuwait shows high diversity in the N- and O-linked glycosylation sites in the G protein between 2020 and 2022

Frontiers in cellular and infection microbiology, 2024, Vol.14, p.1445115

2024

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Neu hinzugefügt... seit 90 Tagen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(62)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Respiratory Syncytial Virus
(49)
Life Sciences & Biomedicine
(42)
Science & Technology
(42)
Humans
(36)
Immunology
(36)
Vaccines
(20)
Respiratory Syncytial Virus Infections - Immunology
(19)
Respiratory Syncytial Virus Infections - Prevention & Control
(19)
Female
(18)
Respiratory Syncytial Virus, Human - Immunology
(18)
Infections
(17)
Respiratory Syncytial Virus Vaccines - Immunology
(17)
Infant
(15)
Medicine, Research & Experimental
(14)
Research & Experimental Medicine
(14)
Viruses
(14)
Virology
(12)
Animals
(11)
Influenza
(11)
Male
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccines
(6)
Vaccine
(5)
Cleveland Clinic Journal Of Medicine
(3)
Deutsche Medizinische Wochenschrift
(2)
Frontiers In Cellular And Infection Microbiology
(2)
Frontiers In Immunology
(2)
Npj Vaccines
(2)
Science
(2)
The Lancet
(2)
Viruses
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(16)

Menü

Weitere Dienste

Einstellungen

Enhanced susceptibility of pediatric airway epithelium to respiratory syncytial virus infection

Long-Term SARS-CoV-2 Findings Related to Persisting Viral Antigen and Inflammation Resemble Those Reported for Influenza Virus and Respiratory Syncytial Virus

Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation

Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection

Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK

Antibody-mediated protection against respiratory syncytial virus in children

Induction of neutralizing antibody responses by AAV5-based vaccine for respiratory syncytial virus in mice

A new RSV vaccine (mResvia) for adults ≥60 years old

Respiratory syncytial virus infection provides protection against severe acute respiratory syndrome coronavirus challenge

Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children

Promising Top-Line Results for RSV Vaccine in Immunocompromised Adults

Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis

Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan

Early-Life Respiratory Syncytial Virus (RSV) Infection Triggers Immunological Changes in Gut-Associated Lymphoid Tissues in a Sex-Dependent Manner in Adulthood

Systematic Review of the Efficacy and Safety of RSV‐Specific Monoclonal Antibodies and Antivirals in Development

The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune Response

Reduced antiviral gene expression and elevated CXCL8 expression in peripheral blood are associated with severe hypoxemia in RSV-infected children

Vaccinations in pulmonary diseases - part 2: herpes zoste, RSV, pneumococcal infection and pertussis

The role of respiratory syncytial virus G protein in immune cell infection and pathogenesis

RSV Neutralizing Antibodies in Dried Blood

Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024

AntigenBoost: enhanced mRNA-based antigen expression through rational amino acid substitution

Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study

Having the conversation: Individualizing RSV vaccination in older patients

Circulation of new lineages of RSV-A and RSV-B in Kuwait shows high diversity in the N- and O-linked glycosylation sites in the G protein between 2020 and 2022

Aktive Filter

Suchergebnisse filtern